Novavax | NVAX - Trade Creditors


Novavax reported $24.58M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Adma Biologics USD 22.52M 1.5M Dec/2025
Agenus USD 82.99M 2.3M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
Cassava Sciences USD 41.65M 4.44M Dec/2025
Geron USD 11.26M 146K Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
MannKind USD 9.03M 1.76M Dec/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 640K 305K Dec/2025
Moderna USD 317M 50M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Novavax USD 24.58M 9.35M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Sanofi EUR 22.93B 927M Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025